Search research articles
Contact Us
Filters
Showing results (41-50 of 159) with videos related to
Page
of 16
Sort By:
European Journal of Heart Failure
|
January 12, 2005
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
Gedske Daugaard, Ulrik Lassen, Peter Bie, et al.
JCO Precision Oncology
|
January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data
Carsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Clinical Laboratory
|
October 17, 2017
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols
Lise B Ahlborn, Mette Madsen, Lars Jonson, et al.
Cancer Biomarkers : Section a of Disease Markers
|
January 26, 2011
Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer
Kristoffer Staal Rohrberg, Birgit Guldhammer Skov, Ulrik Lassen, et al.
Plos One
|
July 26, 2022
Changes in key recruitment performance metrics from 2008-2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov
Mette Brøgger-Mikkelsen, John Robert Zibert, Anders Daniel Andersen, et al.
Frontiers in Oncology
|
April 12, 2021
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
Vinicius Araujo B de Lima, Morten Hansen, Iben Spanggaard, et al.
BJC Reports
|
November 8, 2024
Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer
Andreas Bjerrum, Andreas Frederik Henriksen, Ann Søegaard Knoop, et al.
Plos One
|
June 12, 2014
The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts
Mette K Nedergaard, Karina Kristoffersen, Signe R Michaelsen, et al.
The Oncologist
|
March 24, 2023
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator
Albrecht Stenzinger, Brian Cuffel, Noman Paracha, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 28, 2022
Late effects - the new focus of follow-up
Christoffer Johansen, Annika von Heymann, Bolette S Rafn, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 159) with videos related to
Sort By:
Page
of 16
European Journal of Heart Failure
|
January 12, 2005
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
Gedske Daugaard, Ulrik Lassen, Peter Bie, et al.
JCO Precision Oncology
|
January 23, 2023
Survival Outcomes of Patients With Tropomyosin Receptor Kinase Fusion-Positive Cancer Receiving Larotrectinib Versus Standard of Care: A Matching-Adjusted Indirect Comparison Using Real-World Data
Carsten Bokemeyer, Noman Paracha, Ulrik Lassen, et al.
Clinical Laboratory
|
October 17, 2017
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols
Lise B Ahlborn, Mette Madsen, Lars Jonson, et al.
Cancer Biomarkers : Section a of Disease Markers
|
January 26, 2011
Markers of angiogenesis and epidermal growth factor receptor signalling in patients with pancreatic and gastroesophageal junction cancer
Kristoffer Staal Rohrberg, Birgit Guldhammer Skov, Ulrik Lassen, et al.
Plos One
|
July 26, 2022
Changes in key recruitment performance metrics from 2008-2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov
Mette Brøgger-Mikkelsen, John Robert Zibert, Anders Daniel Andersen, et al.
Frontiers in Oncology
|
April 12, 2021
Immune Cell Profiling of Peripheral Blood as Signature for Response During Checkpoint Inhibition Across Cancer Types
Vinicius Araujo B de Lima, Morten Hansen, Iben Spanggaard, et al.
BJC Reports
|
November 8, 2024
Overall survival after CDK4/6 inhibitor dose reduction in women with metastatic breast cancer
Andreas Bjerrum, Andreas Frederik Henriksen, Ann Søegaard Knoop, et al.
Plos One
|
June 12, 2014
The use of longitudinal 18F-FET MicroPET imaging to evaluate response to irinotecan in orthotopic human glioblastoma multiforme xenografts
Mette K Nedergaard, Karina Kristoffersen, Signe R Michaelsen, et al.
The Oncologist
|
March 24, 2023
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator
Albrecht Stenzinger, Brian Cuffel, Noman Paracha, et al.
Acta Oncologica (Stockholm, Sweden)
|
October 28, 2022
Late effects - the new focus of follow-up
Christoffer Johansen, Annika von Heymann, Bolette S Rafn, et al.
Page
of 16